Christopher Visioli
Director of Finance/CFO en POPULATION HEALTH INVESTMENT CO., INC. .
Perfil
Christopher Visioli es director financiero de Population Health Investment Co. y director financiero y contable de The Medicines Co. Anteriormente, el Sr. Visioli trabajó como Vicepresidente Senior de Estrategia Financiera en The Medicines Co. Se licenció en la Universidad de Cornell y obtuvo un MBA en la Columbia Business School.
Cargos activos de Christopher Visioli
| Empresas | Cargo | Inicio |
|---|---|---|
| POPULATION HEALTH INVESTMENT CO., INC. | Director of Finance/CFO | 11/09/2020 |
Antiguos cargos conocidos de Christopher Visioli.
| Empresas | Cargo | Fin |
|---|---|---|
| THE MEDICINES COMPANY | Director of Finance/CFO | 01/05/2020 |
Formación de Christopher Visioli.
| Cornell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Population Health Investment Co., Inc.
 Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Christopher Visioli
